PharmaEssentia
The Director, Thought Leader Engagement leads the Thought Leader Liaison team to identify, cultivate, and manage relationships with key healthcare professionals and influential individuals in Hematology/Oncology. This role serves as a strategic partner to the Marketing team, driving engagement with Key Opinion Leaders and community-based specialists to shape brand strategy and support implementation through peer-to-peer initiatives. The position involves gathering market insights, monitoring competitive landscapes, and managing KOL relationships to optimize brand performance and commercial outcomes.
Headquarters
Burlington, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
PharmaEssentia is a Taiwan-based global biopharmaceutical company focused on researching, developing, and commercializing best-in-class therapies for blood disorders and other serious diseases. Its portfolio includes Ropeginterferon alfa‑2b (marketed as Besremi) for polycythemia vera and other myeloproliferative neoplasms, and the company conducts clinical trials, medical affairs, and manufacturing activities worldwide. PharmaEssentia provides resources for patients and healthcare professionals and emphasizes innovation in protein engineering and biologics production. It aims to bring effective, scientifically driven treatments to patients through robust R&D and global partnerships.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PharmaEssentia.
Director, Thought Leader Engagement (Southwest)
Genmab
Thought Leader Liaison - Rare Disease (Uplizna)
Amgen
Associate Director, Thought Leader Liaison
Servier
Thought Leader Liaison - Rare Disease (Uplizna)
Sparrow
Associate Director, Thought Leader Liaison, Renal Cell Carcinoma (RCC) - East Region
Eisai
Hematology Thought Leader Liaison
Grifols